Press release
Friedreich’s Ataxia Therapeutics Pipeline Analysis - Cardero Therapeutics, Inc., Edison Pharmaceuticals, Inc., Retrotope, Inc.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/frda-therapeutics-pipeline-analysis/report-sample
*Various Grants from Friedreich's Ataxia Research Alliance (FARA)
Catabasis Pharmaceuticals, Inc. received Kyle Bryant Translational Research award from the FARA for the evaluation of their drug candidate, which is being developed for the treatment of Friedreich’s ataxia.
*Drugs are being developed using natural sources in the Friedreich's Ataxia (FRDA) Therapeutics Pipeline
The research also found that various companies are in the process of developing the drug candidates using natural sources for the treatment of Friedreich's ataxia therapeutics pipeline. Cardero Therapeutics, Inc. is in the process of developing a drug candidate as a sterol using natural source, for the treatment of Friedreich's ataxia.
Browse report at: https://www.psmarketresearch.com/market-analysis/frda-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of Friedreich's ataxia include Cardero Therapeutics, Inc., Edison Pharmaceuticals, Inc., Retrotope, Inc. and others.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Friedreich’s Ataxia Therapeutics Pipeline Analysis - Cardero Therapeutics, Inc., Edison Pharmaceuticals, Inc., Retrotope, Inc. here
News-ID: 1462739 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Friedreich
Friedreich Ataxia Marketed And Pipeline Drugs Analysis During the Forecast Perio …
The Friedreich's Ataxia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Friedreich's Ataxia pipeline products will significantly revolutionize Friedreich's Ataxia market dynamics.
DelveInsight's "Friedreich's Ataxia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Friedreich's Ataxia, historical and forecasted epidemiology as well as the Friedreich's Ataxia market trends in the United States,…
Australian Friedreich Ataxia Therapeutics Market Report with Executive Summary, …
Report Overview
The Australian Friedreich Ataxia (FRDA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Friedreichs Ataxia (FRDA) is the common inherited ataxia in the Australian. FRDA is a genetic, progressive, neurodegenerative movement disorder, that primarily affects the nervous system and the heart with a typical age of onset between…
United Kingdom Friedreich Ataxia Therapeutics Market Report with Executive Summa …
Report Overview
The UK Friedreich Ataxia (FRDA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Friedreichs ataxia (FRDA) is the most common inherited ataxia in the UK. FRDA is a genetic, progressive, neurodegenerative movement disorder, that primarily affects the nervous system and the heart with a typical age of onset…
Friedreich Ataxia Market Analysis By Drug Class(ACE Inhibitors, Beta Blockers, D …
The global Friedreich's Ataxia market size was valued at USD 750 million in 2021 and is projected to reach around USD 2,060 million in 2030 exhibiting a CAGR of 12% in the forecasted period.
The fast research and development activities for manufacturing latest therapeutics for Friedreich's Ataxia treatment, rising inorganic business growth strategies such as acquisitions, collaborations, and others among market players, are expected to upsurge the market growth. However, problems…
Friedreich Ataxia Drug Market to Witness Growth Acceleration | Adverum Biotechno …
Friedreich Ataxia Drug Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report answers questions on the current and future technological advancements and development. It delivers an analysis of main manufactures and geographic regions.
The global Friedreich Ataxia Drug market is segmented by company, region (country), type, application, players, stakeholders, and others. The report includes the opportunities and encounters that are faced by…
Friedreich Ataxia Drug Market Emerging Trends || Leading Players are Edison Phar …
The market study on the global Friedreich Ataxia Drug Market will include the entire ecosystem of the industry, covering five major regions namely North America, Europe, Asia Pacific, Latin America and Middle East & Africa, and the major countries falling under those regions. The study will feature estimates in terms of sales revenue and consumption from 2019 to 2026, at the global level and across the major regions mentioned above.…
